Clinical Trial Update: Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Sintilimab-based regimens (Sintilimab plus Nab-paclitaxel–POF and Sintilimab plus XELOX) with a Lenvatinib-containing arm in H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Lenvatinib (lenvatinib)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Gastric (Stomach) Cancer | Phase 2 | Status: NOT_YET_RECRUITING